PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 4 days 11 minutes
What's on the Radio? 2021 Data Broadcast on Radioligands in Men With CRPC
What's on the Radio? 2021 Data Broadcast on Radioligands in Men With CRPC
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses
Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?
Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?
Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?
Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?
Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold
Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold
Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do
"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"
Asked and Answered: Differentiating Between PARP Inhibitors in First-Line Advanced Ovarian Cancer
Asked and Answered: Differentiating Between PARP Inhibitors in First-Line Advanced Ovarian Cancer
Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists
Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists
Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists
Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists